JAIC
CLBT icon

Josh Arnold Investment Consultant’s Cellebrite CLBT Stock Holding History

Josh Arnold Investment Consultant’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-73,000
Closed -$1.42M – 18
2025
Q1 		$1.42M Buy
+73,000
New +$1.54M 1.18% 9
2024
Q4 		– Sell
-59,850
Closed -$1.01M – 14
2024
Q3 		$1.01M Buy
59,850
+29,850
+100% +$443K 0.82% 8
2024
Q2 		$359K Buy
+30,000
New +$335K 0.3% 18
2024
Q1 		– Sell
-40,000
Closed -$346K – 14
2023
Q4 		$346K Buy
+40,000
New +$311K 0.33% 14
2022
Q2 		– Sell
-10,000
Closed -$64K – 23
2022
Q1 		$64K Buy
+10,000
New +$66.3K 0.06% 22

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Josh Arnold Investment Consultant's CLBT Position: Q2 2025 in Review

Josh Arnold Investment Consultant sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 73,000 shares — an estimated $1.42M sold.

Josh Arnold Investment Consultant first reported a position in CLBT in Q1 2022 and held it in 5 quarters. The position peaked at $1.42M in Q1 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • Josh Arnold Investment Consultant reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • Josh Arnold Investment Consultant sold 73,000 Cellebrite shares in Q2 2025, an estimated $1.42M.
  • Josh Arnold Investment Consultant first reported a position in Cellebrite in Q1 2022 and held it in 5 quarters.
  • Josh Arnold Investment Consultant's Cellebrite position peaked at $1.42M in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Josh Arnold Investment Consultant's 13F filing for Q2 2025, filed 14 Aug 2025.